About Phase I

Early phase (Phase I) clinical trials offer hope to patients with advanced cancers and also advance important science required to find better cancer therapies. They are the initial step in validating new discoveries. The UC Davis Comprehensive Cancer Center is the single institution within the Sacramento region with the infrastructure necessary to safely conduct rigorous early-phase clinical trials.

To fulfill its mission of reducing mortality from advanced cancer, the cancer center launched the Sacramento Citywide Oncology PhasE I program (or SCOPE), a partnership among oncologists throughout the region’s health systems to offer access for any medically eligible patient to Phase I clinical trials at UC Davis.

UC Davis is a “comprehensive cancer center” designated as such by the National Cancer Institute. This prestigious designation provides essential research support that in turn augments cancer treatment options for the community. The UC Davis Comprehensive Cancer Center brings together and takes advantage of exceptional resources at UC Davis in basic, translational and clinical research, as well as the expertise and technologies of our partners at the Lawrence Livermore National Laboratory, Jackson Laboratory (JAX West) and the UC Davis School of Veterinary Medicine. These collaborations enhance the drug discovery and development pipeline, bringing these advances directly to patients who need them.